bullish
Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race
255 Views02 Jun 2018 11:48
Icure Pharm Inc (175250 KS) will offer a total of 1,200,000 shares (100% new rights offering) at ₩44,000 - ₩55,000 which gives a market cap of...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Icure Pharm (175250 KS): High Hope for Transdermal Patch-Type Dementia Treatment Option20 Nov 2021
- Icure Pharm (175250 KS): Post IPO Short Selling Opportunity Checkup10 Jul 2018
- Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race02 Jun 2018
x